Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
It's Class I For Recall Of Smiths Medical Insulin Syringes, FDA Says
Jun 21 2021
•
By
Shawn M. Schmitt
More from Recalls
More from Policy & Regulation